We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-7.37%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$310M
AUM Growth
-$104M
Cap. Flow
-$74.9M
Cap. Flow %
-24.14%
Top 10 Hldgs %
43.58%
Holding
95
New
25
Increased
9
Reduced
24
Closed
33

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$18.9M
2
AGN
Allergan plc
AGN
+$16.4M
3
PFE icon
Pfizer
PFE
+$11M
4
MCK icon
McKesson
MCK
+$8.96M
5
COR icon
Cencora
COR
+$8.86M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$15.2M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$12.1M
3
MEDP icon
Medpace
MEDP
+$10.2M
4
NVS icon
Novartis
NVS
+$8.3M
5
HUM icon
Humana
HUM
+$7.51M

Sector Composition

Rank Sector Weight
1 Healthcare 82.23%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOGC
51
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1.32M 0.43%
122,536
-10,004
-8% -$107K
XGN icon
52
Exagen
XGN
$109M
$1.32M 0.42%
+85,000
New +$1.37M
GYRE icon
53
Gyre Therapeutics
GYRE
$641M
$1.13M 0.36%
30,624
-37,982
-55% -$2.05M
BNGO icon
54
Bionano Genomics
BNGO
$12.3M
$1M 0.32%
2,399
-134
-5% -$146K
ACHV icon
55
Achieve Life Sciences
ACHV
$659M
$892K 0.29%
26,221
– –
WST icon
56
PUT
West Pharmaceutical
WST
$24B
$709K 0.23%
5,000
-4,900
-49% -$675K
VAR
57
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
$524K 0.17%
+4,400
New +$523K
LITS
58
Lite Strategy Inc
LITS
$32.8M
$435K 0.14%
12,943
-62,561
-83% -$2.28M
AXSM icon
59
Axsome Therapeutics
AXSM
$11.2B
$411K 0.13%
20,310
– –
OPK icon
60
CALL
Opko Health
OPK
$985M
$262K 0.08%
+125,300
New +$256K
HTGM
61
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$199K 0.06%
+1,667
New +$336K
LXRX icon
62
Lexicon Pharmaceuticals
LXRX
$1.03B
$62K 0.02%
+20,667
New +$64K
ACAD icon
63
PUT
Acadia Pharmaceuticals
ACAD
$4.43B
– –
-2,055,700
Closed -$54.9M
ACHC icon
64
PUT
Acadia Healthcare
ACHC
$2.76B
– –
-38,400
Closed -$1.34M
AFMD
65
DELISTED
Affimed
AFMD
– –
-26,794
Closed -$769K
BCRX icon
66
BioCryst Pharmaceuticals
BCRX
$2.28B
– –
-522,863
Closed -$1.98M
BCRX icon
67
PUT
BioCryst Pharmaceuticals
BCRX
$2.28B
– –
-38,700
Closed -$147K
CVS icon
68
CVS Health
CVS
$133B
– –
-113,738
Closed -$6.2M
EBS icon
69
Emergent Biosolutions
EBS
$373M
– –
-48,400
Closed -$2.34M
CBIO
70
PUT
Crescent Biopharma
CBIO
$537M
– –
-1,101
Closed -$1.31M
GMED icon
71
Globus Medical
GMED
$10.7B
– –
-102,827
Closed -$4.35M
GSK icon
72
GSK
GSK
$104B
– –
-303,600
Closed -$15.2M
HUM icon
73
Humana
HUM
$43.7B
– –
-28,307
Closed -$7.51M
IDXX icon
74
PUT
Idexx Laboratories
IDXX
$44.1B
– –
-14,400
Closed -$3.96M
INGN icon
75
Inogen
INGN
$175M
– –
-15,189
Closed -$1.01M
1 2
3
4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Sio Capital Management held 95 positions worth $310M, down 25% from $415M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sio Capital Management withdrew a net $74.9M in Q3 2019, closing 33 positions and reducing 24 holdings. Its most notable exit was GSK, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 69% a quarter earlier, followed by Technology.

Against the trend, Sio Capital Management opened a new position in Johnson & Johnson worth $18.6M.

  • Sio Capital Management's largest Q3 2019 buy was Johnson & Johnson: 143,707 shares worth $18.6M.
  • Sio Capital Management added most to GW Pharmaceuticals Plc American Depositary Shares in Q3 2019, an estimated $8.43M increase.
  • Sio Capital Management's biggest Q3 2019 reduction was Medpace, cutting an estimated $10.2M.
  • Sio Capital Management fully exited GSK in Q3 2019, selling an estimated $15.2M.
  • Sio Capital Management's ten largest holdings make up 44% of its $310M portfolio in Q3 2019.
  • Sio Capital Management opened 25 new positions and closed 33 in Q3 2019.
  • Sio Capital Management's portfolio value fell 25% quarter-over-quarter to $310M.

Based on Sio Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.